
Efficacy of bilateral thoracoscopic sympathectomy in a patient with catecholaminergic polymorphic ventricular tachycardia
Author(s) -
Okajima Katsunori,
Kiuchi Kunihiko,
Yokoi Kiminobu,
Teranishi Jin,
Aoki Kosuke,
Shimane Akira,
Nakamura Yoshihide,
Kimura Motoko,
Horikawa Yoshio,
Yoshida Masato,
Maniwa Yoshimasa
Publication year - 2016
Publication title -
journal of arrhythmia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.463
H-Index - 21
eISSN - 1883-2148
pISSN - 1880-4276
DOI - 10.1016/j.joa.2015.07.002
Subject(s) - medicine , catecholaminergic polymorphic ventricular tachycardia , flecainide , sympathectomy , anesthesia , cardiology , ventricular tachycardia , implantable cardioverter defibrillator , ryanodine receptor 2 , ryanodine receptor , calcium , atrial fibrillation
A 27‐year‐old woman with frequent implantable cardioverter defibrillator (ICD) shocks related to catecholaminergic polymorphic ventricular tachycardia (VT) experienced aborted sudden death due to incessant polymorphic VT despite the administration of beta‐blockers, verapamil, and flecainide. Catheter ablation failed to suppress the polymorphic VT. Based on the temporary efficacy of the local anesthetic administered at the left and right cervical sympathetic nerves to suppress VT under an isoproterenol infusion, stepwise, bilateral thoracoscopic sympathectomy was performed. Postoperatively, no further VT or syncopal episodes were documented under ICD telemetry. Bilateral thoracoscopic sympathectomy may be an alternative for patients with drug‐refractory catecholaminergic polymorphic VT.